3,875 reports of this reaction
4.9% of all LIRAGLUTIDE reports
#2 most reported adverse reaction
BLOOD GLUCOSE INCREASED is the #2 most commonly reported adverse reaction for LIRAGLUTIDE, manufactured by Novo Nordisk. There are 3,875 FDA adverse event reports linking LIRAGLUTIDE to BLOOD GLUCOSE INCREASED. This represents approximately 4.9% of all 79,181 adverse event reports for this drug.
Patients taking LIRAGLUTIDE who experience blood glucose increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD GLUCOSE INCREASED is moderately reported among LIRAGLUTIDE users, representing a notable but not dominant share of adverse events.
In addition to blood glucose increased, the following adverse reactions have been reported for LIRAGLUTIDE:
The following drugs have also been linked to blood glucose increased in FDA adverse event reports:
BLOOD GLUCOSE INCREASED has been reported as an adverse event in 3,875 FDA reports for LIRAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD GLUCOSE INCREASED accounts for approximately 4.9% of all adverse event reports for LIRAGLUTIDE, making it one of the most commonly reported side effect.
If you experience blood glucose increased while taking LIRAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.